Matches in SemOpenAlex for { <https://semopenalex.org/work/W1984938201> ?p ?o ?g. }
- W1984938201 endingPage "103" @default.
- W1984938201 startingPage "93" @default.
- W1984938201 abstract "<i>Objective:</i> We evaluated whether immunoblotting is capable of substantiating the posttreatment clinical assessment of patients with erythema migrans (EM), the hallmark of early Lyme borreliosis. <i>Methods:</i> In 50 patients, seroreactivity to different antigens of <i>Borrelia burgdorferi</i> sensu lato was analyzed by a recombinant immunoblot test (IB) in consecutive serum samples from a minimum follow-up period of 1 year. Antigens in the IgG test were decorin-binding protein A, internal fragment of p41 (p41i), outer surface protein C (OspC), p39, variable major protein-like sequence expressed (VlsE), p58 and p100; those in the IgM test were p41i, OspC and p39. Immune responses were correlated with clinical and treatment-related parameters. <i>Results:</i> Positive IB results were found in 50% before, in 57% directly after therapy and in 44% by the end of the follow-up for the IgG class, and in 36, 43 and 12% for the IgM class. In acute and convalescence phase sera, VlsE was most immunogenic on IgG testing (60 and 70%), and p41i (46 and 57%) and OspC (40 and 57%) for the IgM class. By the end of the follow-up, only the anti-p41i IgM response was significantly decreased to 24%. <i>Conclusions:</i> No correlation was found between IB results and treatment-related parameters. Thus, immunoblotting does not add to the clinical assessment of EM patients after treatment." @default.
- W1984938201 created "2016-06-24" @default.
- W1984938201 creator A5011062072 @default.
- W1984938201 creator A5028570749 @default.
- W1984938201 creator A5031259286 @default.
- W1984938201 creator A5062474988 @default.
- W1984938201 creator A5082839472 @default.
- W1984938201 creator A5085797102 @default.
- W1984938201 date "2008-01-01" @default.
- W1984938201 modified "2023-10-16" @default.
- W1984938201 title "Immunoblot Analysis of the Seroreactivity to Recombinant <i>Borrelia burgdorferi </i>sensu lato Antigens, Including VlsE, in the Long-Term Course of Treated Patients with Erythema Migrans" @default.
- W1984938201 cites W1511165980 @default.
- W1984938201 cites W1590520110 @default.
- W1984938201 cites W1596352322 @default.
- W1984938201 cites W1601661953 @default.
- W1984938201 cites W1701714503 @default.
- W1984938201 cites W1745693202 @default.
- W1984938201 cites W1780111211 @default.
- W1984938201 cites W1830124154 @default.
- W1984938201 cites W1909069060 @default.
- W1984938201 cites W1952060001 @default.
- W1984938201 cites W1964783243 @default.
- W1984938201 cites W1989466848 @default.
- W1984938201 cites W1993249060 @default.
- W1984938201 cites W2001373300 @default.
- W1984938201 cites W2006963240 @default.
- W1984938201 cites W2007534126 @default.
- W1984938201 cites W2008561997 @default.
- W1984938201 cites W2013613069 @default.
- W1984938201 cites W2018774638 @default.
- W1984938201 cites W2019720599 @default.
- W1984938201 cites W2032719386 @default.
- W1984938201 cites W2033750491 @default.
- W1984938201 cites W2052164570 @default.
- W1984938201 cites W2052662005 @default.
- W1984938201 cites W2057266757 @default.
- W1984938201 cites W2070608627 @default.
- W1984938201 cites W2080220630 @default.
- W1984938201 cites W2084493677 @default.
- W1984938201 cites W2084572987 @default.
- W1984938201 cites W2088089656 @default.
- W1984938201 cites W2090671888 @default.
- W1984938201 cites W2091177595 @default.
- W1984938201 cites W2100143368 @default.
- W1984938201 cites W2100584234 @default.
- W1984938201 cites W2103128190 @default.
- W1984938201 cites W2104202918 @default.
- W1984938201 cites W2109744277 @default.
- W1984938201 cites W2113896734 @default.
- W1984938201 cites W2118763814 @default.
- W1984938201 cites W2122681831 @default.
- W1984938201 cites W2124170739 @default.
- W1984938201 cites W2125641599 @default.
- W1984938201 cites W2129877729 @default.
- W1984938201 cites W2132192943 @default.
- W1984938201 cites W2132546705 @default.
- W1984938201 cites W2133076235 @default.
- W1984938201 cites W2133685117 @default.
- W1984938201 cites W2134469540 @default.
- W1984938201 cites W2158027112 @default.
- W1984938201 cites W2162689245 @default.
- W1984938201 cites W2162873756 @default.
- W1984938201 cites W2164581303 @default.
- W1984938201 cites W2328446417 @default.
- W1984938201 cites W2405795808 @default.
- W1984938201 cites W2413268716 @default.
- W1984938201 cites W2756563076 @default.
- W1984938201 cites W2887092304 @default.
- W1984938201 cites W29803754 @default.
- W1984938201 cites W77475293 @default.
- W1984938201 doi "https://doi.org/10.1159/000111505" @default.
- W1984938201 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/18216470" @default.
- W1984938201 hasPublicationYear "2008" @default.
- W1984938201 type Work @default.
- W1984938201 sameAs 1984938201 @default.
- W1984938201 citedByCount "19" @default.
- W1984938201 countsByYear W19849382012014 @default.
- W1984938201 countsByYear W19849382012015 @default.
- W1984938201 countsByYear W19849382012016 @default.
- W1984938201 countsByYear W19849382012017 @default.
- W1984938201 crossrefType "journal-article" @default.
- W1984938201 hasAuthorship W1984938201A5011062072 @default.
- W1984938201 hasAuthorship W1984938201A5028570749 @default.
- W1984938201 hasAuthorship W1984938201A5031259286 @default.
- W1984938201 hasAuthorship W1984938201A5062474988 @default.
- W1984938201 hasAuthorship W1984938201A5082839472 @default.
- W1984938201 hasAuthorship W1984938201A5085797102 @default.
- W1984938201 hasBestOaLocation W19849382012 @default.
- W1984938201 hasConcept C104317684 @default.
- W1984938201 hasConcept C147483822 @default.
- W1984938201 hasConcept C159047783 @default.
- W1984938201 hasConcept C159654299 @default.
- W1984938201 hasConcept C203014093 @default.
- W1984938201 hasConcept C2777553296 @default.
- W1984938201 hasConcept C2779159148 @default.
- W1984938201 hasConcept C2779906846 @default.
- W1984938201 hasConcept C2780508971 @default.
- W1984938201 hasConcept C2909371672 @default.